Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 161-166 , February 2010

Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods

  • Shih-Fang Lin

      Affiliations

    • Institute of Information Systems and Applications, National Tsing Hua University, Hsinchu 300, Taiwan
    • Corresponding Author InformationCorresponding author at: 830 Room, EECS Building, Institute of Information Systems and Applications, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 30013, Taiwan. Tel.: +886 3 5715131x34199; fax: +886 3 5723694.
    • ,
  • Ke-Ting Xiao

      Affiliations

    • Department of Computer Science, National Tsing Hua University, Hsinchu 300, Taiwan
    • ,
  • Yu-Ting Huang

      Affiliations

    • Department of Computer Science, National Tsing Hua University, Hsinchu 300, Taiwan
    • ,
  • Chung-Cheng Chiu

      Affiliations

    • Department of Computer Science, National Tsing Hua University, Hsinchu 300, Taiwan
    • ,
  • Von-Wun Soo

      Affiliations

    • Institute of Information Systems and Applications, National Tsing Hua University, Hsinchu 300, Taiwan
    • Department of Computer Science, National Tsing Hua University, Hsinchu 300, Taiwan
    • Department of Computer Science and Information Engineering, National University of Kaohsiung, Kaohsiung 811, Taiwan

Received 15 August 2008 ,Revised 3 September 2009 ,Accepted 8 September 2009.

References 

  1. Lazarou J, Bruce H, Pomeranz , Paul N, Corey . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. The Journal of American Medical Association. 1998;279:1200–1205
  2. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scandinavian Journal of Primary Health Care. 2003;21:153–158
  3. Kuhlmann J, Mück W. Clinical-pharmacological strategies to assess drug interaction potential during drug development. Drug Safety. 2001;24(10):715–725
  4. Hauben M, Zhou X. Quantitative methods in pharmacovigilance focus on signal detection. Drug Safety. 2003;26(3):159–186
  5. van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems of adverse drug reactions. Pharmacoepidemiology and Drug Safety. 2002;11:3–10
  6. Henegar C, Bousquet C, Lillo-Le Louët A, Degoulet P, Jaulent MC. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance. Computer in Biology and Medicine. 2006;36(7):748–767
  7. Chen X, Ji ZL, Chen YZ. TTD: therapeutic target database. Nucleic Acid Research. 2002;30(1):412–415
  8. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research. 2006;34:668–672
  9. Ji ZL, Han LY, Yap CW, Sun LZ, Chen X, Chen YZ. Drug. adverse reaction target database (DART): proteins related to adverse drug reactions. Drug Safety. 2003;26(10):689–690
  10. Sun LZ, Ji ZL, Chen X, Wang JF, Chen YZ. ADME-AP: a database of ADME associated proteins. Bioinformatics. 2002;18(12):1699–1700
  11. Enzyme nomenclature database. http://au.expasy.org/enzyme/ [accessed: 01.07.07].
  12. GPCRDB: information system for G protein-coupled receptors (GPCRs). http://www.gpcr.org/7tm/ [accessed: 01.07.07].
  13. NucleaRDB: an information system for nuclear receptors. http://www.receptors.org/NR/ [accessed: 01.07.07].
  14. Ligand-Gated Ion Channel database. http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php [accessed: 01.07.07].
  15. Watts DJ, Strogatz SH. Collective dynamics of small-world networks. Nature. 1998;393:440–442

PII: S0933-3657(09)00161-4

doi: 10.1016/j.artmed.2009.11.002

Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 161-166 , February 2010

Article Tools

* Image Usage & Resolution